70183-220 : Inpefa 200 mg Oral Tablet
| NDC: | 70183-220 |
| Labeler: | Lexicon Pharmaceuticals Inc. |
| Product Type: | Human Prescription Drug |
| Drug Name: |  Inpefa |
| Dosage Form: | Oral Tablet |
| Application #: | NDA216203 |
| Rev. Date: |
NDC Package Codes:
- 70183-220-07: 1 BLISTER PACK IN 1 CARTON (70183‑220‑07) / 7 TABLET IN 1 BLISTER PACK
- 70183-220-30: 30 TABLET IN 1 BOTTLE (70183‑220‑30)
- 70183-220-90: 90 TABLET IN 1 BOTTLE (70183‑220‑90)
Active Ingredients:
- Sotagliflozin
Dosage Strength:
- 200 mg
Pharmaceutical Classes:
- P-Glycoprotein Inhibitors [MoA]
- Sodium-Glucose Cotransporter 2 Inhibitor [EPC]
- Sodium-Glucose Transporter 2 Inhibitors [MoA]
Related Products:
Based on records with the same trade name.- 70183-240 Inpefa 400 mg Oral Tablet by Lexicon Pharmaceuticals Inc.
- 70183-221 Inpefa 200 mg Oral Tablet by Lexicon Pharmaceuticals, Inc.
- 70183-241 Inpefa 400 mg Oral Tablet by Lexicon Pharmaceuticals, Inc.
NDC QR Code
Scan the QR code below to easily reference this data in the future:
< Prev: 70183-125Next: 70183-221 >
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.